Zydus Lifesciences’ arm completes acquisition of 85.6% equity shares of Amplitude Surgical SA

30 Jul 2025 Evaluate

Zydus Lifesciences’ step down subsidiary -- Zydus MedTech (France) SAS has completed block acquisition of 85.6% equity shares of Amplitude Surgical SA, France (Target Entity). As a result, Zydus MedTech France now holds 85.6% of the share capital and voting rights of the Target Entity. 

Zydus MedTech France will file on July 30, 2025, a simplified mandatory tender offer for all the remaining outstanding shares of the Target Entity at a price of Euro 6.25 per share, identical to the price paid for the Block Acquisition. Considering the undertaking received from seven shareholders to participate in tender offer representing in aggregate 4.7% of share capital and voting rights, Zydus MedTech France will be in a position to hold more than 90% of the capital and voting rights of the Target Entity upon completion of the Offer. Zydus MedTech France will subsequently request the implementation of a squeeze-out.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×